Ads
related to: fda approved stem cell treatments
Search results
Gene therapy and employee benefits: from science fiction to medical reality
BenefitsPRO· 2 days agoAt the rate research and approvals have been accelerating, the 2020s may be remembered as the decade...
Insulin may be a thing of the past thanks to this groundbreaking diabetes cure
BGR· 6 days agoDiabetes is one of the world’s biggest health problems, an illness that doesn’t have a cure. You can...
...Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy...
Morningstar· 6 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell< ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Forrest City Times-Herald· 2 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval ...
Allen Institute's cell lines could lead to new drugs for hypertrophic cardiomyopathy
FierceBiotech· 21 hours agoNow, the Allen Institute for Cell Science has taken a step toward solving the problem with six new...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 hours agoMitsubishi Tanabe Pharma America to Highlight Expansive ALS Research at the European Network to Cure ALS (ENCALS) 2024 Meeting PR Newswire JERSEY CITY, N.J., June 5, 2024 Data will be presented from eight abstracts spanning preclinical to real-world
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 5 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
AI cancer screening programs are booming, but you'll likely have to pay for them yourself
CNBC· 6 days agoThe FDA has approved nearly 600 radiology AI program since 2019, but most aren't covered by Medicare...
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Valley City Times Record· 2 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple myeloma who have ...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Forrest City Times-Herald· 2 days agoThe rates of deep and sustained MRD negativity were associated with improved progression-free survival (PFS) with DARZALEX FASPRO®-based quadruplet induction...